Those who take Tysabri (natalizumab) to manage their MS are more likely to suffer a relapse during pregnancy if they stop taking the drug before they conceive, the first study found.
From: https://www.webmd.com/multiple-sclerosis/news/20180208/ms-drug-poses-hard-choices-for-women-wanting-kids?src=RSS_PUBLIC
No comments:
Post a Comment